These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7920257)

  • 21. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.
    Solomon A; Schmidt W; Havemann K
    J Immunol; 1976 Sep; 117(3):1010-4. PubMed ID: 60445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.
    Rivier J; Lahrichi SL; Gulyas J; Erchegyi J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W
    J Med Chem; 1998 Jul; 41(14):2614-20. PubMed ID: 9651165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global fluctuations of the immunoglobulin domains under physiological conditions.
    Kawata Y; Hamaguchi K
    Biopolymers; 1990; 30(3-4):389-94. PubMed ID: 2126211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L
    J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective and facile cyclization of N-chloroacetylated peptides from the C4 domain of HIV Gp120 in LiCl/DMF solvent systems.
    Robey FA
    J Pept Res; 2000 Sep; 56(3):115-20. PubMed ID: 11007268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI.
    Epp O; Colman P; Fehlhammer H; Bode W; Schiffer M; Huber R; Palm W
    Eur J Biochem; 1974 Jun; 45(2):513-24. PubMed ID: 4851220
    [No Abstract]   [Full Text] [Related]  

  • 29. Azo cyclization: peptide cyclization via azo bridge formation.
    Fridkin G; Gilon C
    J Pept Res; 2002 Aug; 60(2):104-11. PubMed ID: 12102723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-component 'double-click' approach to peptide stapling.
    Lau YH; Wu Y; de Andrade P; Galloway WR; Spring DR
    Nat Protoc; 2015 Apr; 10(4):585-94. PubMed ID: 25763835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiophene-2,3-Dialdehyde Enables Chemoselective Cyclization on Unprotected Peptides, Proteins, and Phage Displayed Peptides.
    Wei T; Li D; Zhang Y; Tang Y; Zhou H; Liu H; Li X
    Small Methods; 2022 Nov; 6(11):e2201164. PubMed ID: 36156489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Blind Test of Computational Technique for Predicting the Likelihood of Peptide Sequences to Cyclize.
    Booth J; Alexandru-Crivac CN; Rickaby KA; Nneoyiegbe AF; Umeobika U; McEwan AR; Trembleau L; Jaspars M; Houssen WE; Shalashilin DV
    J Phys Chem Lett; 2017 May; 8(10):2310-2315. PubMed ID: 28475844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on the cyclization tendency of backbone cyclic tetrapeptides.
    Besser D; Olender R; Rosenfeld R; Arad O; Reissmann S
    J Pept Res; 2000 Dec; 56(6):337-45. PubMed ID: 11152292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of cysteinyl prolyl ester for the synthesis of cyclic peptides containing an RGD sequence and their biological activity measurement.
    Yamada A; Takei T; Kawakami T; Taniguchi Y; Sekiguchi K; Hojo H
    Front Chem; 2024; 12():1391678. PubMed ID: 38873405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymatic cyclization of L-glutamine and L-glutaminyl peptides.
    MESSER M
    Nature; 1963 Mar; 197():1299. PubMed ID: 13935130
    [No Abstract]   [Full Text] [Related]  

  • 36. Foreword: What the Generalist Should Know About REI.
    Berga SL
    Clin Obstet Gynecol; 2020 Dec; 63(4):685-686. PubMed ID: 33136823
    [No Abstract]   [Full Text] [Related]  

  • 37. Destabilizing loop swaps in the CDRs of an immunoglobulin VL domain.
    Helms LR; Wetzel R
    Protein Sci; 1995 Oct; 4(10):2073-81. PubMed ID: 8535243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolytic excision and in situ cyclization of a bioactive loop from an REI-VL presentation scaffold.
    Helms LR; Wetzel R
    Protein Sci; 1994 Jul; 3(7):1108-13. PubMed ID: 7920257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffold.
    Lee G; Chan W; Hurle MR; DesJarlais RL; Watson F; Sathe GM; Wetzel R
    Protein Eng; 1993 Sep; 6(7):745-54. PubMed ID: 8248098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A paradigm for drug discovery using a conformation from the crystal structure of a presentation scaffold.
    Zhao B; Helms LR; DesJarlais RL; Abdel-Meguid SS; Wetzel R
    Nat Struct Biol; 1995 Dec; 2(12):1131-7. PubMed ID: 8846226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.